As of 2025-09-18, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -112.43 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 185.00 GBP, the upside of Faron Pharmaceuticals Oy is -160.77%.
Based on its market price of 185.00 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 160.77%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -112.43 - -112.43 | -112.43 | -160.77% |
| P/E | (170.89) - (321.54) | (203.49) | -210.0% |
| DDM - Stable | (189.46) - (560.21) | (374.84) | -302.6% |
| DDM - Multi | (88.47) - (205.10) | (123.80) | -166.9% |
| Market Cap (mil) | 220.38 |
| Beta | 0.42 |
| Outstanding shares (mil) | 1.19 |
| Enterprise Value (mil) | 228.07 |
| Market risk premium | 5.98% |
| Cost of Equity | 9.96% |
| Cost of Debt | 5.00% |
| WACC | 9.73% |